KPMG report: REIT considerations (COVID-19)
KPMG report: REIT considerations (COVID-19)
The coronavirus (COVID-19) pandemic is causing uncertainty and changing the business environment for the real estate investment trust (REIT) industry.
- Read a March 2020 report [PDF 101 KB] that delves into special considerations for existing and newly formed REITs acquiring distressed investments: What’s News in Tax: Distressed Debt—REIT considerations
- Read a March 2020 report [PDF 80 KB] that provides a high-level summary for widely held REITs using elective stock dividends to build up cash reserves: What’s News in Tax: The Use of Elective Stock Dividends by a Publicly Offered REIT
© 2024 KPMG LLP, a Delaware limited liability partnership and a member firm of the KPMG global organization of independent member firms affiliated with KPMG International Limited, a private English company limited by guarantee. All rights reserved.
For more detail about the structure of the KPMG global organization please visit https://kpmg.com/governance.
The KPMG name and logo are trademarks used under license by the independent member firms of the KPMG global organization. KPMG International Limited is a private English company limited by guarantee and does not provide services to clients. No member firm has any authority to obligate or bind KPMG International or any other member firm vis-à-vis third parties, nor does KPMG International have any such authority to obligate or bind any member firm. The information contained herein is of a general nature and is not intended to address the circumstances of any particular individual or entity. Although we endeavor to provide accurate and timely information, there can be no guarantee that such information is accurate as of the date it is received or that it will continue to be accurate in the future. No one should act on such information without appropriate professional advice after a thorough examination of the particular situation. For more information, contact KPMG's Federal Tax Legislative and Regulatory Services Group at: + 1 202 533 3712, 1801 K Street NW, Washington, DC 20006.